GYNECOLOGIC ONCOLOGY: Sharad Ghamande, MD, received $158K from VentiRx Pharmaceuticals

Sharad Ghamande, MD, received $158K from VentiRx Pharmaceuticals for β€œA randomized, double-blind, placebo-controlled phase II study of VTX 2337 in combination with pegylated liposomal doxorubicin (PLD) in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.”

Written by
Heather Hopkins

My work explores the relationship between the universality of myth and life as performance.

With influences as diverse as Machiavelli and Joni Mitchell, new combinations are generated from both explicit and implicit meanings.

Ever since I was a teenager I have been fascinated by the essential unreality of the zeitgeist. What starts out as yearning soon becomes corroded into a manifesto of professional courtesy, leaving only a sense of what could have been and the dawn of a new reality.

As momentary replicas become clarified through emergent and repetitive practice, the viewer is left with an epitaph for the outposts of our culture.

View all articles
Written by Heather Hopkins

About Jagwire

Jagwire is the official source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia. Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanitiesΒ and the health sciences. Have a story to share with Jaguar Nation? Contact the Division of Communications & Marketing.